Pharma Marketing News Vol. 9, #4: April 2010
Welcome to the APRIL 2010 issue of Pharma Marketing News.
Pharma Marketing News Vol. 9, #4: April 2010
Welcome to the APRIL 2010 issue of Pharma Marketing News.
Pharma’s Friend: Social Media
With a friend like that, who needs enemies?!
MicroBlogging About “Newsworthy” Events: Should Pharma Follow FDA’s Lead?
Many pharmaceutical corporate Twitter accounts are devoted to posting news about the company, including news about new research results relating to one of its...
What If, God Forbid, Sally Field Broke Her Leg?
As written in wikipedia, "Break a leg" is a well-known saying in theatre which means "good luck." It is typically said to actors and...
What’s Your Social Media Implementation Plan?
Last week I posted "Where's Your Social Media Crisis Management Plan," which received some good responses from readers, including Sanofi-Aventis (S-A). Dennis Urbaniak, VP...
Are Pharma Marketers Drug Pushers?
"Critics may not like branded drugs pushed directly to consumers but it is clear that it brings people in the doctor's door," wrote...
Is This Juvederm XC DTC Print Ad “Fair and Balanced?”
Take a look at the Juvederm XC ad, which I found in this week's New Yorker Magazine, which (coincidentally) includes an article about treatment...
A Little More Math and a Little Less Jingo Pharma Journalism Please
Bnet journalist Jim Edwards cites the Seroquel professional ad shown on the left and suggests that it is implying that "If Calling Mom Makes...
What Has Sanofi-Aventis Learned from Its Facebook Experience?
NOTE: This interview has been rescheduled for Tuesday, April 6, 2010 at 2:00 PM EDT.
Dennis Urbaniak, VP U.S. Diabetes and former VP of Innovation...
